The digital/software development agency will be creating solutions to predict disease behaviour in a 5 year contract.
April 22, 2019, CHENNAI: India based digital/software agency, Untitled Interactive has been awarded a five year contract to develop Machine Learning systems to sturdy & predict disease behaviour in patients suffering from diabetes, cancer & heart ailments.
The pitch which went on for more than a year, had the start-up company developing multiple prototypes to enable machine learning with the highest predictability rate among the competition. The contract is a major milestone for the company with its solutions being deployed on a wide scale. The terms of the contract including client names & detailed scope of work are not public due to an agreement between the company & the client.
“We have always looked out for greater ways to save lives. With the advantages artificial intelligence systems provide to go through data and find patterns is unprecedented. Untitled Interactive has shown strength in developing systems in a rapid manner with ingenious ideas. The system once deployed is expected to save millions of lives.” said a spokesperson representing the client.
“Untitled Interactive has always upheld the belief that technology is to be utilised for a much greater purpose. With this contract, Untitled is on the map for bigger challenges to steer humanity towards a better promising future. The ML systems will be the first of their kind to enable disease prediction before it even shows up on the physical body. Our teams have been closely associated with medical researchers to understand the progression of diseases and how patterns can be identified to ensure timely alerts to the patients years ahead, stopping regression.”, said Mr Arjun Krishnan, Director at Untitled Interactive.
About Untitled Interactive
Based in Delhi, Bangalore & Chennai, Untitled Interactive is an award winning digital advertising & software development start-up servicing major FMCG brands in India & the USA. The agency’s software development division is responsible for the creation & implementation of several projects in the automation & pharmaceutical sector. The company’s diversification into digital advertising & development has allowed cutting edge technology development in the field of Machine Learning & Artificial Intelligence systems.
